RUMORED BUZZ ON HIV TREATMENT

It's very well recognized that IL-2 is actually a pleiotropic cytokine positioned within the crossroads of T cell activation and regulation. As such, it really is imperative to engineer an IL-2 molecule that is certainly biased in the direction of effector cells bearing the intermediate affinity receptor, for example naïve and memory CD8+ T cells